Abstract
Molecular therapy is emerging as a potential strategy for the treatment of many diseases. Correct regulation of gene expression is essential for both, to normal development and proper functioning of the all the organisms. Even after four decades of intensive research, it is still a major problem from regulatory and technical point of view, to replace defective genes. The technology of decoy oligonucleotides has received considerable attention to treat and cure a variety of diseases and abnormal physiological conditions, because they provide a rational way to design and selective regulation of a specific gene expression. Decoy oligonucleotides are widely used as inhibitors of specific gene expression because they can offer exciting possibility of expression and blocking of a particular gene without any changes in the functions of other genes. Advances in the decoy oligonucleotides are rapidly paving the way to new insights into the origin and treatment of inflammatory, cancer and/or other immune disorders. The review covers the progress achieved towards the development of decoy oligonucleotides as a potential strategy in a new class of molecular therapy.
Keywords: DNA, decoy oligonucleotide, NF-κB decoy, oligonucleotides delivery, transcription factor
Current Drug Discovery Technologies
Title:Application of Decoy Oligonucleotides as Novel Therapeutic Strategy: A Contemporary Overview
Volume: 10 Issue: 1
Author(s): Mohammad Zaki Ahmad, Sohail Akhter, Neha Mallik, Mohammad Anwar, Wajda Tabassum and Farhan Jalees Ahmad
Affiliation:
Keywords: DNA, decoy oligonucleotide, NF-κB decoy, oligonucleotides delivery, transcription factor
Abstract: Molecular therapy is emerging as a potential strategy for the treatment of many diseases. Correct regulation of gene expression is essential for both, to normal development and proper functioning of the all the organisms. Even after four decades of intensive research, it is still a major problem from regulatory and technical point of view, to replace defective genes. The technology of decoy oligonucleotides has received considerable attention to treat and cure a variety of diseases and abnormal physiological conditions, because they provide a rational way to design and selective regulation of a specific gene expression. Decoy oligonucleotides are widely used as inhibitors of specific gene expression because they can offer exciting possibility of expression and blocking of a particular gene without any changes in the functions of other genes. Advances in the decoy oligonucleotides are rapidly paving the way to new insights into the origin and treatment of inflammatory, cancer and/or other immune disorders. The review covers the progress achieved towards the development of decoy oligonucleotides as a potential strategy in a new class of molecular therapy.
Export Options
About this article
Cite this article as:
Zaki Ahmad Mohammad, Akhter Sohail, Mallik Neha, Anwar Mohammad, Tabassum Wajda and Jalees Ahmad Farhan, Application of Decoy Oligonucleotides as Novel Therapeutic Strategy: A Contemporary Overview, Current Drug Discovery Technologies 2013; 10 (1) . https://dx.doi.org/10.2174/1570163811310010009
DOI https://dx.doi.org/10.2174/1570163811310010009 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antidepressants: Update on Benefits and Risks
Current Psychopharmacology Dermatologic Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Oral Appliances Improve Sleep Quality in Japanese Patients with Obstructive Sleep Apnea
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pleiotropic Effects of Nifedipine on Atherosclerosis
Current Pharmaceutical Design The Socioeconomic Effects of Uncontrolled Hypertension
Current Vascular Pharmacology Inflammation Fueling Atrial Fibrillation Substrate: Seeking Ways to "Cool" the Heart
Medicinal Chemistry Increased Salt Sensitivity in Obese Hypertension: Role of the Sympathetic Nervous System
Current Hypertension Reviews Pyrrolo-isoxazole: A Key Molecule with Diverse Biological Actions
Mini-Reviews in Medicinal Chemistry The Path from Anti Parkinson Drug Selegiline and Rasagiline to Multifunctional Neuroprotective Anti Alzheimer Drugs Ladostigil and M30
Current Alzheimer Research Thrombophilia in Pregnancy: Maternal and Fetal Implications
Current Women`s Health Reviews 1,4-Benzothiazines-A Biologically Attractive Scaffold
Mini-Reviews in Medicinal Chemistry The Cardiac Antihypertrophic Effects of Cyclic GMP-Generating Agents: An Experimental Framework for Novel Treatments of Left Ventricular Remodeling
Vascular Disease Prevention (Discontinued) Epigenetic Control of Hypertension by DNA Methylation: A Real Possibility
Current Pharmaceutical Design Myocardial Perfusion SPECT Imaging in Patients after Coronary Revascularization
Vascular Disease Prevention (Discontinued) Post Chikungunya Chronic Arthritis: Systemic Inflammatory Status Triggering Acute Coronary Syndrome
Current Rheumatology Reviews The Influence of Metabolism on the MAO-B Inhibitory Potency of Selegiline
Current Medicinal Chemistry Managing Erectile Dysfunction in Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Vitamin B<sub>12</sub> Deficiency Among the Healthy Jordanian Adult Population: Diagnostic Levels, Symptomology and Risk Factors
Endocrine, Metabolic & Immune Disorders - Drug Targets Polyphenols: Inflammation
Current Pharmaceutical Design Phenomics of Vascular Disease: The Systematic Approach to the Combination Therapy
Current Vascular Pharmacology